The estimation of treatment effects on medical costs and cost effectiveness measures is complicated by the need to account for non-independent censoring, skewness and the effects of confounders. In this dissertation, we develop several cost and cost-effectiveness tools that account for these issues. Since medical costs are often collected from observational claims data, we investigate propensity score methods such as covariate adjustment, stratification, inverse probability weighting and doubly robust weighting. We also propose several doubly robust estimators for common cost effectiveness measures. Lastly, we explore the role of big data tools and machine learning algorithms in cost estimation. We show how these modern techniques can be ap...
Background/Introduction In the absence of evidence from randomised controlled trials on the relative...
The field of cost-effectiveness analysis (CEA) deals with the comparison of health interventions bas...
Projecting the future cancer care cost is critical in health economics research and policy making. A...
The estimation of treatment effects on medical costs and cost effectiveness measures is complicated ...
The estimation of treatment effects on medical costs and cost effectiveness measures is complicated ...
Informed healthcare policy decisions must be driven by consideration of an intervention\u27s effecti...
Observational studies are a useful resource for evaluating the cost and cost-effectiveness of medica...
This thesis explores the use of observational microdata in cost-effectiveness analysis. The applicat...
Informed healthcare policy decisions must be driven by consideration of an intervention\u27s effecti...
Recent studies show that appropriate statistical analysis of cost data may lead to more cost-effecti...
Cost effectiveness analysis (CEA) of randomised trials are an important source of evidence for infor...
This paper provides an educational review covering the consideration of costs for cost-effectiveness...
The motivation for this research was the study of a medical cost data set from a clinical trial. If ...
CONTEXT: Statistical models employed in analysing patient-level cost and effectiveness data need to...
Treatment allocations in observational studies are nonrandom and result in the confounding problem a...
Background/Introduction In the absence of evidence from randomised controlled trials on the relative...
The field of cost-effectiveness analysis (CEA) deals with the comparison of health interventions bas...
Projecting the future cancer care cost is critical in health economics research and policy making. A...
The estimation of treatment effects on medical costs and cost effectiveness measures is complicated ...
The estimation of treatment effects on medical costs and cost effectiveness measures is complicated ...
Informed healthcare policy decisions must be driven by consideration of an intervention\u27s effecti...
Observational studies are a useful resource for evaluating the cost and cost-effectiveness of medica...
This thesis explores the use of observational microdata in cost-effectiveness analysis. The applicat...
Informed healthcare policy decisions must be driven by consideration of an intervention\u27s effecti...
Recent studies show that appropriate statistical analysis of cost data may lead to more cost-effecti...
Cost effectiveness analysis (CEA) of randomised trials are an important source of evidence for infor...
This paper provides an educational review covering the consideration of costs for cost-effectiveness...
The motivation for this research was the study of a medical cost data set from a clinical trial. If ...
CONTEXT: Statistical models employed in analysing patient-level cost and effectiveness data need to...
Treatment allocations in observational studies are nonrandom and result in the confounding problem a...
Background/Introduction In the absence of evidence from randomised controlled trials on the relative...
The field of cost-effectiveness analysis (CEA) deals with the comparison of health interventions bas...
Projecting the future cancer care cost is critical in health economics research and policy making. A...